LU91293I2 - Maropitant ou un sel pharmaceutiquement acceptabled'un tel composé, y compris le sel de monohydrate de citrate. cerenia - Google Patents

Maropitant ou un sel pharmaceutiquement acceptabled'un tel composé, y compris le sel de monohydrate de citrate. cerenia

Info

Publication number: LU91293I2
Authority: LU; Luxembourg
Prior art keywords: cerenia; maropitant; salt; compound; pharmaceutically acceptable
Prior art date: 1991-05-31

Application number

LU91293C

Other languages

English (en)

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-05-31

Filing date

2006-12-06

Publication date

2007-02-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24845673&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU91293(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-12-06 Application filed by Pfizer filed Critical Pfizer

2007-02-06 Publication of LU91293I2 publication Critical patent/LU91293I2/fr

Links

OMPCVMLFFSQFIX-CONSDPRKSA-N (2s,3s)-2-benzhydryl-n-[(5-tert-butyl-2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine Chemical compound COC1=CC=C(C(C)(C)C)C=C1CN[C@@H]1[C@H](C(C=2C=CC=CC=2)C=2C=CC=CC=2)N2CCC1CC2 OMPCVMLFFSQFIX-CONSDPRKSA-N 0.000 title 1
PGVSXRHFXJOMGW-YBZGWEFGSA-N (2s,3s)-2-benzhydryl-n-[(5-tert-butyl-2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine;2-hydroxypropane-1,2,3-tricarboxylic acid;hydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O.COC1=CC=C(C(C)(C)C)C=C1CN[C@@H]1[C@H](C(C=2C=CC=CC=2)C=2C=CC=CC=2)N2CCC1CC2 PGVSXRHFXJOMGW-YBZGWEFGSA-N 0.000 title 1
YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 title 1
229940069233 cerenia Drugs 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
229960002505 maropitant Drugs 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Pulmonology (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

LU91293C 1991-05-31 2006-12-06 Maropitant ou un sel pharmaceutiquement acceptabled'un tel composé, y compris le sel de monohydrate de citrate. cerenia LU91293I2 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US70840491A	1991-05-31	1991-05-31
PCT/US1992/003317 WO1992021677A1 (fr)	1991-05-31	1992-04-28	Derives de quinuclidine

Publications (1)

Publication Number	Publication Date
LU91293I2 true LU91293I2 (fr)	2007-02-06

Family

ID=24845673

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU91293C LU91293I2 (fr)	1991-05-31	2006-12-06	Maropitant ou un sel pharmaceutiquement acceptabled'un tel composé, y compris le sel de monohydrate de citrate. cerenia

Country Status (41)

Country	Link
US (3)	US5807867A (fr)
EP (1)	EP0587723B1 (fr)
JP (2)	JPH0733386B2 (fr)
KR (1)	KR100214905B1 (fr)
CN (1)	CN1048492C (fr)
AP (1)	AP299A (fr)
AT (1)	ATE135006T1 (fr)
AU (1)	AU657552B2 (fr)
BG (1)	BG61694B1 (fr)
BR (1)	BR9206073A (fr)
CA (1)	CA2102179C (fr)
CZ (1)	CZ281403B6 (fr)
DE (4)	DE9290063U1 (fr)
DK (1)	DK0587723T3 (fr)
EG (1)	EG19944A (fr)
ES (1)	ES2084361T3 (fr)
FI (1)	FI114475B (fr)
GR (1)	GR3019687T3 (fr)
GT (1)	GT199200028A (fr)
HU (1)	HU217548B (fr)
IE (1)	IE72473B1 (fr)
IL (1)	IL102008A (fr)
IS (1)	IS1611B (fr)
LU (1)	LU91293I2 (fr)
MA (1)	MA22539A1 (fr)
MX (1)	MX9202554A (fr)
NL (1)	NL300250I2 (fr)
NO (2)	NO302701B1 (fr)
NZ (2)	NZ270673A (fr)
OA (1)	OA09867A (fr)
PL (1)	PL171379B1 (fr)
PT (1)	PT100546B (fr)
RO (1)	RO110499B1 (fr)
RU (1)	RU2103269C1 (fr)
SK (1)	SK390692A3 (fr)
TW (1)	TW204349B (fr)
UA (1)	UA27776C2 (fr)
UY (1)	UY23422A1 (fr)
WO (1)	WO1992021677A1 (fr)
YU (1)	YU48995B (fr)
ZA (1)	ZA923942B (fr)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE9290063U1 (de) *	1991-05-31	1994-02-24	Pfizer Inc., New York, N.Y.	Chinuclidin-Derivate
UA39168C2 (uk) *	1991-06-20	2001-06-15	Пфайзер, Інк.	Фторалкоксифенільні похідні піперидину або хінуклідину, що є антагоністами речовини p і фармацевтична композиція на їх основі
ATE208376T1 (de) *	1992-08-19	2001-11-15	Pfizer	Substituierte benzylamin-stickstoff enthaltende nichtaromatische heterocyclen
ATE147385T1 (de) *	1992-11-12	1997-01-15	Pfizer	Chinuclidin derivat als substanz p antagonist
US5344830A (en) *	1992-12-10	1994-09-06	Merck & Co., Inc.	N,N-diacylpiperazine tachykinin antagonists
IL109646A0 (en) *	1993-05-19	1994-08-26	Pfizer	Heteroatom substituted alkyl benzylamino-quinuclidines
JP2822274B2 (ja) *	1993-05-19	1998-11-11	ファイザー製薬株式会社	Ｐ物質拮抗剤としてのヘテロ原子置換アルキルベンジルアミノキヌクリジン類
US5393762A (en) *	1993-06-04	1995-02-28	Pfizer Inc.	Pharmaceutical agents for treatment of emesis
EP0653208A3 (fr) *	1993-11-17	1995-10-11	Pfizer	Antagonistes de la substance P pour le traitement et la prévention de l'erythème solaire.
EP0659409A3 (fr) *	1993-11-23	1995-08-09	Pfizer	Antagonistes de la substance P pour l'inhibition de l'angiogénése.
EP0655246A1 (fr) *	1993-11-30	1995-05-31	Pfizer Inc.	Antagonistes de la substance P pour le traitement des maladies causées par Helicobacter Pylori ou d'autres bacteries spirales, ureare-positives, gram-négatives
IL116249A (en) *	1994-12-12	2003-07-06	Pfizer	Nk-1 receptor antagonists for the treatment of neuronal damage and stroke
PE8798A1 (es) *	1995-07-17	1998-03-02	Pfizer	Procedimiento de separacion de los enantiomeros del 1-azabiciclo[2.2.2] octan-3-amina, 2-(difenilmetil) -n- [[2-metoxi-5-(1-metiletil) fenil] metil]
TW458774B (en)	1995-10-20	2001-10-11	Pfizer	Antiemetic pharmaceutical compositions
IL123740A0 (en) *	1997-03-28	1998-10-30	Pfizer	NK-1 receptor antagonists for the treatment of delayed emesis
NZ329807A (en) *	1997-04-23	2000-07-28	Pfizer	NK-1 receptor antagonists and P receptor antagonists 2-Diarylmethyl-3-amino-1-azabicyclo[2.2.2]octane derivatives and amino substituted N-containing rings as agents for treating irritable bowel syndrome
ID25818A (id) *	1998-03-19	2000-11-09	Takeda Chemical Industries Ltd	Senyawa-senyawa heterosiklik, produksinya dan penggunaannya
US6255320B1 (en) *	1999-06-01	2001-07-03	Pfizer Inc.	Polymorphs of a crystalline azo-bicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
US6387925B1 (en) *	1999-06-01	2002-05-14	Pfizer Inc.	Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions
US6262067B1 (en) *	1999-06-22	2001-07-17	Pfizer Inc.	Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions
JP2001172178A (ja) *	1999-10-25	2001-06-26	Pfizer Prod Inc	偏頭痛治療用のｎｋ−１レセプターアンタゴニスト及びエレトリプタン
DK1246806T3 (da)	1999-11-03	2008-06-16	Amr Technology Inc	Aryl- og heteroarylsubstituerede tetrahydroisoquinoliner og anvendelse deraf til blokering af genoptagelse af norepinefrin, dopsmin og serotonin
US7163949B1 (en)	1999-11-03	2007-01-16	Amr Technology, Inc.	4-phenyl substituted tetrahydroisoquinolines and use thereof
IL142810A0 (en) *	2000-05-03	2002-03-10	Pfizer Prod Inc	Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
WO2002004455A2 (fr)	2000-07-11	2002-01-17	Albany Molecular Research, Inc	Tetrahydroisoquinoleines 4-phenyle substituees et leur utilisation therapeutique
US20020049211A1 (en) *	2000-09-06	2002-04-25	Sobolov-Jaynes Susan Beth	Combination treatment for depression and anxiety
EP1192952A3 (fr) *	2000-09-28	2003-03-26	Pfizer Products Inc.	Composition pour le traitement de la dépression et de l'anxieté contenant un antagoniste du recepteur NK-3 et un antagoniste du récepteur NK-1
JP2005504029A (ja) *	2001-07-20	2005-02-10	ファイザー・プロダクツ・インク	犬の好ましくない行動を改善するためのｎｋ−１受容体アンタゴニストの使用
US6686507B2 (en)	2002-03-06	2004-02-03	Pfizer Inc	Purification of 2-methoxy-5-trifluoromethoxybenzaldehyde
GB0220581D0 (en) *	2002-09-04	2002-10-09	Novartis Ag	Organic Compound
US6861526B2 (en)	2002-10-16	2005-03-01	Pfizer Inc.	Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine
WO2004064717A2 (fr) *	2003-01-21	2004-08-05	Yeda Research And Development Co. Ltd.	Copolymere 1 pour le traitement de maladies enteriques inflammatoires
US20050136487A1 (en) *	2003-10-27	2005-06-23	Meyer Donald W.	Transmissible spongiform encephalopathy detection in cervids, sheep and goats
DE602004028150D1 (de) *	2003-11-26	2010-08-26	Pfizer Prod Inc	Aminopyrazolderivate als gsk-3-inhibitoren
CA2554346C (fr) *	2004-01-30	2009-11-17	Pfizer Products Inc.	Formulations parenterales comprenant une beta-cyclodextrine et un agent de conservation
CN1913893A (zh)	2004-01-30	2007-02-14	辉瑞产品有限公司	改善麻醉恢复的nk－1受体拮抗剂
BRPI0507334A (pt)	2004-02-02	2007-07-03	Pfizer Prod Inc	processo para a preparação de -1(2s,3s)-2-benzidril-n-(5-terc-butil-2-metoxibenzila)q uinuclidin-3-amina
KR101389246B1 (ko)	2004-07-15	2014-04-24	브리스톨-마이어스스퀴브컴파니	아릴- 및 헤테로아릴-치환된 테트라히드로이소퀴놀린, 및 이것의 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 용도
US8362075B2 (en)	2005-05-17	2013-01-29	Merck Sharp & Dohme Corp.	Cyclohexyl sulphones for treatment of cancer
NZ565111A (en)	2005-07-15	2011-10-28	Amr Technology Inc	Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
KR20080048502A (ko)	2005-09-29	2008-06-02	머크 앤드 캄파니 인코포레이티드	멜라노코르틴-4 수용체 조절제로서의 아실화스피로피페리딘 유도체
GB0603041D0 (en)	2006-02-15	2006-03-29	Angeletti P Ist Richerche Bio	Therapeutic compounds
JP5489333B2 (ja)	2006-09-22	2014-05-14	メルク・シャープ・アンド・ドーム・コーポレーション	脂肪酸合成阻害剤を用いた治療の方法
US20110218176A1 (en)	2006-11-01	2011-09-08	Barbara Brooke Jennings-Spring	Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
CN101190330A (zh)	2006-11-30	2008-06-04	深圳市鼎兴生物医药技术开发有限公司	胆碱酯酶在拮抗速激肽药物中的应用
CA2674436C (fr)	2007-01-10	2012-07-17	Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.	Indazoles a substitution amide utilises comme inhibiteurs de la poly(adp-ribose)polymerase (parp)
AU2008208920A1 (en)	2007-01-24	2008-07-31	Glaxo Group Limited	Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or R(-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an NK1
AU2008233662B2 (en)	2007-04-02	2012-08-23	Msd K.K.	Indoledione derivative
EP2170076B1 (fr)	2007-06-27	2016-05-18	Merck Sharp & Dohme Corp.	Dérivés de 4-carboxybenzylamino utilisés en tant qu'inhibiteurs de l'histone désacétylase
AU2009222122A1 (en)	2008-03-03	2009-09-11	Tiger Pharmatech	Tyrosine kinase inhibitors
US9156812B2 (en)	2008-06-04	2015-10-13	Bristol-Myers Squibb Company	Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
UA105182C2 (ru)	2008-07-03	2014-04-25	Ньюрексон, Інк.	Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
US8691825B2 (en)	2009-04-01	2014-04-08	Merck Sharp & Dohme Corp.	Inhibitors of AKT activity
ES2528404T3 (es)	2009-05-12	2015-02-10	Bristol-Myers Squibb Company	Formas cristalinas de (S)-7-([1,2,4]triazol[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2,3,4-tetrahidroisoquinolina y sus usos
AU2010247763B2 (en)	2009-05-12	2015-12-24	Albany Molecular Research, Inc.	7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydroisoquinoline and use thereof
ES2446971T3 (es)	2009-05-12	2014-03-11	Albany Molecular Research, Inc.	Tetrahidroisoquinolinas sustituidas con arilo, heteroarilo, y heterociclo y su uso
US8859776B2 (en)	2009-10-14	2014-10-14	Merck Sharp & Dohme Corp.	Substituted piperidines that increase p53 activity and the uses thereof
WO2011163330A1 (fr)	2010-06-24	2011-12-29	Merck Sharp & Dohme Corp.	Nouveaux composés hétérocycliques utilisés comme inhibiteurs de erk
CA2805265A1 (fr)	2010-08-02	2012-02-09	Merck Sharp & Dohme Corp.	Inhibition a mediation par interference arn de catenine (proteine associee a cadherine), expression du gene beta 1 (ctnnb1) a l'aide de petit acide nucleique interferent (sian)
HRP20191232T1 (hr)	2010-08-17	2019-11-01	Sirna Therapeutics Inc	Inhibicija, posredovana rna interferencijom, ekspresije gena virusa hepatitisa b (hbv) korištenjem kratkih interferirajućih nukleinskih kiselina (sina)
EP2608669B1 (fr)	2010-08-23	2016-06-22	Merck Sharp & Dohme Corp.	Nouveaux dérivés de pyrazolo[1,5-a]pyrimidine utilisés comme inhibiteurs de mtor
US8946216B2 (en)	2010-09-01	2015-02-03	Merck Sharp & Dohme Corp.	Indazole derivatives useful as ERK inhibitors
US9242981B2 (en)	2010-09-16	2016-01-26	Merck Sharp & Dohme Corp.	Fused pyrazole derivatives as novel ERK inhibitors
DK2632472T3 (en)	2010-10-29	2018-03-19	Sirna Therapeutics Inc	RNA INTERFERENCE-MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERRING NUCLEIC ACIDS (SINA)
EP2654748B1 (fr)	2010-12-21	2016-07-27	Merck Sharp & Dohme Corp.	Dérivés d'indazole utiles en tant qu'inhibiteurs de erk
AU2012245455A1 (en)	2011-04-21	2013-10-31	Merck Sharp & Dohme Corp.	Insulin-Like Growth Factor-1 Receptor inhibitors
ES2672099T3 (es)	2011-07-04	2018-06-12	Irbm - Science Park S.P.A.	Antagonistas del receptor NK-1 para el tratamiento de la neovascularización corneal
EP2770987B1 (fr)	2011-10-27	2018-04-04	Merck Sharp & Dohme Corp.	Nouveaux composés qui sont des inhibiteurs d'erk
EP2844261B1 (fr)	2012-05-02	2018-10-17	Sirna Therapeutics, Inc.	Compositions de petit acide nucléique interférent (sina)
JP6280554B2 (ja)	2012-09-28	2018-02-14	メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋＳｈａｒｐ＆ＤｏｈｍｅＣｏｒｐ．	Ｅｒｋ阻害剤である新規化合物
HK1215170A1 (zh)	2012-11-14	2016-08-19	The Johns Hopkins University	治療精神分裂症的方法和組合物
AU2013352568B2 (en)	2012-11-28	2019-09-19	Merck Sharp & Dohme Llc	Compositions and methods for treating cancer
KR102196882B1 (ko)	2012-12-20	2020-12-30	머크 샤프 앤드 돔 코포레이션	Hdm2 억제제로서의 치환된 이미다조피리딘
US9540377B2 (en)	2013-01-30	2017-01-10	Merck Sharp & Dohme Corp.	2,6,7,8 substituted purines as HDM2 inhibitors
US20160194368A1 (en)	2013-09-03	2016-07-07	Moderna Therapeutics, Inc.	Circular polynucleotides
US10975084B2 (en)	2016-10-12	2021-04-13	Merck Sharp & Dohme Corp.	KDM5 inhibitors
IL312486B2 (en)	2017-04-10	2025-05-01	Chase Therapeutics Corp	NK1 antagonist combination and method for treating synucleinopathies
CN106977512B (zh) *	2017-05-04	2019-01-01	海门慧聚药业有限公司	制备马罗匹坦游离碱的方法
KR20200026920A (ko)	2017-06-30	2020-03-11	체이스 테라퓨틱스 코포레이션	우울증을 치료하기 위한 nk-1 길항제 조성물 및 우울증 치료에 사용하는 방법
WO2019094312A1 (fr)	2017-11-08	2019-05-16	Merck Sharp & Dohme Corp.	Inhibiteurs de prmt5
WO2019094311A1 (fr)	2017-11-08	2019-05-16	Merck Sharp & Dohme Corp.	Inhibiteurs de prmt5
CN111918647A (zh)	2018-02-26	2020-11-10	圣拉斐尔医院有限公司	用于治疗眼痛的nk-1拮抗剂
KR102102109B1 (ko) *	2018-07-10	2020-04-20	성균관대학교산학협력단	N-벤즈히드릴 퀴뉴클리딘 유도체를 포함하는 나트륨 누출 채널 억제용 조성물
EP3833667B1 (fr)	2018-08-07	2024-03-13	Merck Sharp & Dohme LLC	Inhibiteurs de prmt5
CN112805006B (zh)	2018-08-07	2024-09-24	默沙东有限责任公司	Prmt5抑制剂
EP3833668B1 (fr)	2018-08-07	2025-03-19	Merck Sharp & Dohme LLC	Inhibiteurs de prmt5
EP4117673A1 (fr)	2020-03-11	2023-01-18	Ospedale San Raffaele S.r.l.	Traitement d'une déficience en cellules souches
AT527172A1 (de)	2023-04-25	2024-11-15	Vetviva Richter Gmbh	Maropitantformulierung

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX18467A (es) *	1988-11-23	1993-07-01	Pfizer	Agentes terapeuticos de quinuclidinas
AU648317B2 (en) *	1990-06-01	1994-04-21	Pfizer Inc.	3-amino-2-aryl quinuclidines, process for their preparation and pharmaceutical compositions containing them
DE4026743A1 (de) *	1990-08-24	1992-02-27	Teves Gmbh Alfred	Blockiergeschuetzte bremsanlage fuer kraftfahrzeuge
US5716965A (en) *	1991-05-22	1998-02-10	Pfizer Inc.	Substituted 3-aminoquinuclidines
DE9290063U1 (de) *	1991-05-31	1994-02-24	Pfizer Inc., New York, N.Y.	Chinuclidin-Derivate
ATE195867T1 (de) *	1991-09-20	2000-09-15	Glaxo Group Ltd	Neue medizinische indikation für tachykinin- antagonisten
GB9218334D0 (en) *	1992-08-28	1992-10-14	Ici Plc	Heterocyclic compounds
US5340826A (en) *	1993-02-04	1994-08-23	Pfizer Inc.	Pharmaceutical agents for treatment of urinary incontinence
US5393762A (en) *	1993-06-04	1995-02-28	Pfizer Inc.	Pharmaceutical agents for treatment of emesis
EP0655246A1 (fr) *	1993-11-30	1995-05-31	Pfizer Inc.	Antagonistes de la substance P pour le traitement des maladies causées par Helicobacter Pylori ou d'autres bacteries spirales, ureare-positives, gram-négatives
US5576317A (en) *	1994-12-09	1996-11-19	Pfizer Inc.	NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
PT785198E (pt) *	1996-01-19	2000-11-30	Lonza Ag	Processo para a producao de 3-quinuclidinol opticamente activo.
US5990125A (en) *	1996-01-19	1999-11-23	Pfizer Inc.	NK-1 receptor antagonists for the treatment of cancer

1992
- 1992-04-28 DE DE9290063U patent/DE9290063U1/de not_active Expired - Lifetime
- 1992-04-28 BR BR9206073A patent/BR9206073A/pt not_active Application Discontinuation
- 1992-04-28 RU RU93058555A patent/RU2103269C1/ru active Protection Beyond IP Right Term
- 1992-04-28 AU AU19901/92A patent/AU657552B2/en not_active Expired
- 1992-04-28 CA CA002102179A patent/CA2102179C/fr not_active Expired - Lifetime
- 1992-04-28 DE DE200612000066 patent/DE122006000066I2/de active Active
- 1992-04-28 DE DE69208877T patent/DE69208877T2/de not_active Expired - Lifetime
- 1992-04-28 DK DK92912601.9T patent/DK0587723T3/da active
- 1992-04-28 EP EP92912601A patent/EP0587723B1/fr not_active Expired - Lifetime
- 1992-04-28 CZ CS923906A patent/CZ281403B6/cs not_active IP Right Cessation
- 1992-04-28 UA UA93004096A patent/UA27776C2/uk unknown
- 1992-04-28 RO RO93-01581A patent/RO110499B1/ro unknown
- 1992-04-28 AT AT92912601T patent/ATE135006T1/de active
- 1992-04-28 US US08/211,120 patent/US5807867A/en not_active Expired - Lifetime
- 1992-04-28 JP JP5500353A patent/JPH0733386B2/ja not_active Expired - Lifetime
- 1992-04-28 DE DE1992608877 patent/DE122006000066I1/de active Pending
- 1992-04-28 SK SK3906-92A patent/SK390692A3/sk not_active IP Right Cessation
- 1992-04-28 HU HU9303393A patent/HU217548B/hu active Protection Beyond IP Right Term
- 1992-04-28 WO PCT/US1992/003317 patent/WO1992021677A1/fr not_active Ceased
- 1992-04-28 PL PL92301472A patent/PL171379B1/pl unknown
- 1992-04-28 KR KR1019930703649A patent/KR100214905B1/ko not_active Expired - Lifetime
- 1992-04-28 ES ES92912601T patent/ES2084361T3/es not_active Expired - Lifetime
- 1992-05-05 TW TW081103509A patent/TW204349B/zh not_active IP Right Cessation
- 1992-05-11 AP APAP/P/1992/000384A patent/AP299A/en active
- 1992-05-26 IL IL10200892A patent/IL102008A/en active Protection Beyond IP Right Term
- 1992-05-26 UY UY23422A patent/UY23422A1/es not_active IP Right Cessation
- 1992-05-29 IS IS3871A patent/IS1611B/is unknown
- 1992-05-29 ZA ZA923942A patent/ZA923942B/xx unknown
- 1992-05-29 NZ NZ270673A patent/NZ270673A/en not_active IP Right Cessation
- 1992-05-29 YU YU56492A patent/YU48995B/sh unknown
- 1992-05-29 NZ NZ242956A patent/NZ242956A/en not_active IP Right Cessation
- 1992-05-29 MX MX9202554A patent/MX9202554A/es unknown
- 1992-05-29 PT PT100546A patent/PT100546B/pt not_active IP Right Cessation
- 1992-05-29 GT GT199200028A patent/GT199200028A/es unknown
- 1992-05-29 MA MA22826A patent/MA22539A1/fr unknown
- 1992-05-30 EG EG28492A patent/EG19944A/xx active
- 1992-05-30 CN CN92104129A patent/CN1048492C/zh not_active Expired - Lifetime
- 1992-07-01 IE IE921729A patent/IE72473B1/en not_active IP Right Cessation
1993
- 1993-11-26 BG BG98248A patent/BG61694B1/bg unknown
- 1993-11-29 NO NO934312A patent/NO302701B1/no not_active IP Right Cessation
- 1993-11-29 FI FI935297A patent/FI114475B/fi not_active IP Right Cessation
- 1993-11-30 OA OA60442A patent/OA09867A/en unknown
1994
- 1994-10-05 JP JP6241456A patent/JP2645225B2/ja not_active Expired - Lifetime
1995
- 1995-01-24 US US08/377,552 patent/US6222038B1/en not_active Expired - Lifetime
1996
- 1996-04-19 GR GR960401066T patent/GR3019687T3/el unknown
1997
- 1997-04-30 US US08/846,909 patent/US5939433A/en not_active Expired - Lifetime
2006
- 2006-12-06 LU LU91293C patent/LU91293I2/fr unknown
- 2006-12-06 NL NL300250C patent/NL300250I2/nl unknown
2007
- 2007-03-09 NO NO2007003C patent/NO2007003I2/no unknown

Also Published As

Publication number	Publication date
KR100214905B1 (ko)	1999-08-02
CN1048492C (zh)	2000-01-19
SK278788B6 (sk)	1998-02-04
BG61694B1 (bg)	1998-03-31
IS1611B (is)	1996-10-18
IS3871A (is)	1992-12-02
IE72473B1 (en)	1997-04-23
FI935297L (fi)	1993-11-29
GT199200028A (es)	1993-11-20
DK0587723T3 (da)	1996-04-01
NZ270673A (en)	1997-07-27
CZ281403B6 (cs)	1996-09-11
ES2084361T3 (es)	1996-05-01
UY23422A1 (es)	1992-11-12
NO934312L (no)	1993-11-29
IL102008A0 (en)	1992-12-30
ATE135006T1 (de)	1996-03-15
EG19944A (en)	1997-02-27
WO1992021677A1 (fr)	1992-12-10
IL102008A (en)	1995-12-08
AP299A (en)	1994-01-14
JPH07285965A (ja)	1995-10-31
IE921729A1 (en)	1992-12-02
US6222038B1 (en)	2001-04-24
DE122006000066I1 (de)	2007-03-22
YU56492A (sh)	1995-03-27
RU2103269C1 (ru)	1998-01-27
NO2007003I2 (no)	2011-04-18
SK390692A3 (en)	1998-02-04
MA22539A1 (fr)	1992-12-31
HU217548B (hu)	2000-02-28
GR3019687T3 (en)	1996-07-31
NL300250I1 (nl)	2007-02-01
PL171379B1 (en)	1997-04-30
YU48995B (sh)	2003-04-30
HUT70151A (en)	1995-09-28
JPH0733386B2 (ja)	1995-04-12
PT100546A (pt)	1993-08-31
TW204349B (fr)	1993-04-21
BG98248A (bg)	1994-07-29
AP9200384A0 (en)	1992-07-31
JPH06504292A (ja)	1994-05-19
MX9202554A (es)	1992-11-01
RO110499B1 (ro)	1996-01-30
OA09867A (en)	1994-08-15
EP0587723B1 (fr)	1996-03-06
CZ390692A3 (en)	1994-02-16
PT100546B (pt)	1999-12-31
ZA923942B (en)	1993-11-29
US5807867A (en)	1998-09-15
EP0587723A1 (fr)	1994-03-23
DE9290063U1 (de)	1994-02-24
DE122006000066I2 (de)	2007-12-06
FI935297A0 (fi)	1993-11-29
NL300250I2 (nl)	2007-03-01
BR9206073A (pt)	1994-12-06
NO934312D0 (no)	1993-11-29
NZ242956A (en)	1995-06-27
US5939433A (en)	1999-08-17
NO2007003I1 (no)	2007-03-26
CA2102179C (fr)	1998-10-27
FI114475B (fi)	2004-10-29
HU9303393D0 (en)	1994-03-28
DE69208877T2 (de)	1996-07-25
CA2102179A1 (fr)	1992-12-01
AU1990192A (en)	1993-01-08
DE69208877D1 (de)	1996-04-11
CN1067428A (zh)	1992-12-30
NO302701B1 (no)	1998-04-14
UA27776C2 (uk)	2000-10-16
AU657552B2 (en)	1995-03-16
JP2645225B2 (ja)	1997-08-25

Publication	Publication Date	Title
LU91293I2 (fr)	2007-02-06	Maropitant ou un sel pharmaceutiquement acceptabled'un tel composé, y compris le sel de monohydrate de citrate. cerenia
DE59300018D1 (de)	1994-12-08	Fungizide Azolylmethyl-fluorcycloproplylderivate.
LU88842I2 (fr)	1997-01-27	Nebivolol optionnellement sous forme d'un sel ou d'un hydrate pharmaceutiquement acceptable en particulier hydroclorure de Nebivolol
USD272887S (en)	1984-03-06	Clip for game goal nets
GB9225131D0 (en)	1993-01-20	Fungicidal active compound combinations
EP0649308A4 (fr)	1994-06-22	Prevention de l'hemolyse.
ZA934324B (en)	1994-01-13	Fungicidal (2-aryl-2-substituted)ethyl-1,2,4-triazoles
ATE120185T1 (de)	1995-04-15	Biozide verbindungen.
ZA91315B (en)	1991-11-27	Fungicidal active compound combinations
MX9207407A (es)	1993-06-01	Mejora de la biodisponibilidad de agentes terapeuticos proteoliticamente labiles.
ZA91314B (en)	1991-11-27	Fungicidal active compound combinations
ZA929405B (en)	1993-06-07	2-(Heteroaryloxyphenoxy) alkylsulfonates useful as herbicidal agents.
GB9024873D0 (en)	1991-01-02	Fungicidal compounds
DE69110365D1 (de)	1995-07-20	Fungizide Acylamidobenamide.
USD277726S (en)	1985-02-26	Riser stabilizer for sprinkler system pipes
DE69016122D1 (de)	1995-03-02	Biozide Verbindungen.
IT1215344B (it)	1990-02-08	Procedimento per la preparazione di composti ad attivita' anti-ulcera.
ZA92816B (en)	1993-07-05	Benzimidazole compounds.
Cerridwen	1989	Paleoecology of Pleistocene Mollusca from the Ironshore Formation, Grand Cayman, BWI
OA09328A (en)	1992-09-15	"Heterocyclic compounds".
ZA929195B (en)	1993-05-24	2-(heteroaryloxyphenoxy) alkylsulfonates useful as herbicidal agents.
DE69009900D1 (de)	1994-07-21	Biozide Azoxim-Verbindungen.
GB9125589D0 (en)	1992-01-29	Fungicidal compounds
GB9112696D0 (en)	1991-07-31	Process for the preparation of biocidal compounds
GB2242131B (en)	1993-05-26	Fungicidal active compound combinations